GEN-MKT-18-7897-A
Apr 2, 2019 | Biopharma, Blogs, Pharma | 0 comments
New technologies can transform a laboratory’s throughput and efficiency. At Alturas, if we try out a new technology, we ask:
When we look at the convenience, uptime, and overall data that we’re getting from microflow LC-MS/MS with the SCIEX OptiFlow™ Turbo V source – we know we’re getting better results.
In our work, we analyze large molecules from biological fluids and matrices. The traditional approach, using ligand binding assays, can have real selectivity problems – sometimes even stopping a therapeutic in late stage development. Microflow LC and an optimized source system has us declaring: Problem solved!
I recently gave a webinar called, Soup to Nuts of Large Molecule LC-MS/MS Bioanalysis, and you can watch it on-demand now >
In this blog, I’ll share a Q&A based on some of our experiences. It might have you asking if you should switch to microflow LC-MS/MS for your large molecule bioanalysis, too.
Eight Things You Want to Know About Microflow LC-MS/MS and the OptiFlow Turbo V Source
We hope our answers have been helpful to you! If you’d like more details about our work, please watch this video.
Learn more about the SCIEX OptiFlow Turbo V Source >
As regulatory scrutiny increases and detection requirements tighten, laboratories are facing a new question: How can TFA be measured reliably, sensitively, and at scale?
Glycosylation is one of the more structurally diverse and biologically impactful PTMs in protein therapeutics. Both N‑linked and O‑linked glycans influence protein folding, stability, and biological activity. Given these effects on biotherapeutics, glycosylation is a closely monitored critical quality attribute (CQA). Comprehensive and site‑specific characterization of glycosylation is essential for informed decision‑making throughout drug discovery and development.
Warranty expiration is more than an administrative milestone—it is a transition point that can significantly impact instrument uptime, laboratory productivity, operating budgets, and scientific outcomes.
Posted by
You must be logged in to post a comment.
Share this post with your network